The Latest in B Cell Lymphoma

Kymriah cost effectiveness depends on long-term outcomes

September 17, 2018

B Cell Lymphoma

Pruritus linked to wide variety of cancers

September 16, 2018

New mantle cell trials launching

September 14, 2018

Venetoclax label now includes MRD data

September 12, 2018

MRD data added to venetoclax label

September 12, 2018

B Cell Lymphoma

TP53 mutation plus complex karyotype equals poor prognosis

September 10, 2018

ASCO updates guidance on prophylaxis for adults with cancer-related immunosuppression

September 7, 2018

B Cell Lymphoma

Novartis nabs first CAR T approval in Canada

September 7, 2018

First CAR T-cell therapy approved in Canada

September 7, 2018

England green-lights coverage of one CAR T-cell therapy

September 6, 2018

B Cell Lymphoma

CAR T-cell therapy will soon be available in England, NHS says

September 6, 2018

B Cell Lymphoma

Adverse events outweigh promise of SGN-CD70A against NHL

August 30, 2018

Predicting early outcomes in DLBCL

August 30, 2018

B Cell Lymphoma

New BTK inhibitor under review in China

August 29, 2018

NICE says CAR T-cell therapy isn’t cost-effective

August 29, 2018

B Cell Lymphoma